BLOOD LIPIDS AND HUMAN ATHEROSCLEROSIS

被引：71

作者：

GOFMAN, JW

JONES, HB

LYON, TP

LINDGREN, F

STRISOWER, B

COLMAN, D

HERRING, V

机构：

来源：

CIRCULATION | 1952年 / 5卷 / 01期

关键词：

D O I：

10.1161/01.CIR.5.1.119

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：119 / 134

页数：16

共 12 条

[1]

CHAIKOFF IL, UNPUB ULTRACENTRIFUG

[2] THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT .1. THE INHIBITION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN ALLOXAN DIABETES .2. THE EFFECT OF ALLOXAN DIABETES ON THE RETROGRESSION OF EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS [J].

DUFF, GL ;

MCMILLAN, GC .

JOURNAL OF EXPERIMENTAL MEDICINE, 1949, 89 (06) :611-630

[3] THE ROLE OF LIPIDS AND LIPOPROTEINS IN ATHEROSCLEROSIS [J].

GOFMAN, JW ;

LINDGREN, F ;

ELLIOTT, H ;

MANTZ, W ;

HEWITT, J ;

STRISOWER, B ;

HERRING, V .

SCIENCE, 1950, 111 (2877) :166-&

[4] BLOOD LIPIDS AND HUMAN ATHEROSCLEROSIS [J].

GOFMAN, JW ;

JONES, HB ;

LINDGREN, FT ;

LYON, TP ;

ELLIOTT, HA ;

STRISOWER, B .

CIRCULATION, 1950, 2 (02) :161-178

[5]

GOFMAN JW, 1951, J GERONTOL, V6, P105

[6] BLOOD LIPIDS AND HUMAN ATHEROSCLEROSIS .2. THE INFLUENCE OF HEPARIN UPON LIPOPROTEIN METABOLISM [J].

GRAHAM, DM ;

LYON, TP ;

GOFMAN, JW ;

JONES, HB ;

YANKLEY, A ;

SIMONTON, J ;

WHITE, S .

CIRCULATION, 1951, 4 (05) :666-673

[7]

JONES HB, 1951, AM J MED, V11, P271

[8]

KENDALL F, UNPUB ULTRACENTRIFUG

[9] THE ULTRACENTRIFUGAL CHARACTERIZATION AND ISOLATION OF HUMAN BLOOD LIPIDS AND LIPOPROTEINS, WITH APPLICATIONS TO THE STUDY OF ATHEROSCLEROSIS [J].

LINDGREN, FT ;

ELLIOTT, HA ;

GOFMAN, JW .

JOURNAL OF PHYSICAL AND COLLOID CHEMISTRY, 1951, 55 (01) :80-93

[10]

LINDGREN FT, UNPUB CHEM CHARACTER

← 1 2 →